These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17404898)

  • 21. The association between adaptive and cognitive deficits in geriatric chronic schizophrenic patients.
    Harvey PD; Sukhodolsky D; Parrella M; White L; Davidson M
    Schizophr Res; 1997 Oct; 27(2-3):211-8. PubMed ID: 9416650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between cognitive defects and the course of schizophrenia. Initial study of a rehabilitation programme participants].
    Hanuszkiewicz I; Cechnicki A; Kalisz A
    Psychiatr Pol; 2007; 41(4):539-50. PubMed ID: 18046984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early-onset schizophrenia patients.
    Jepsen JR; Fagerlund B; Pagsberg AK; Christensen AM; Nordentoft M; Mortensen EL
    Scand J Psychol; 2013 Oct; 54(5):363-70. PubMed ID: 23786210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological correlates of cognitive insight in schizophrenia.
    Orfei MD; Spoletini I; Banfi G; Caltagirone C; Spalletta G
    Psychiatry Res; 2010 Jun; 178(1):51-6. PubMed ID: 20452049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
    Sota TL; Heinrichs RW
    Compr Psychiatry; 2004; 45(5):415-21. PubMed ID: 15332206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive functioning related to quality of life in schizophrenia.
    Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.
    Cruz BF; Resende CB; Carvalhaes CF; Cardoso CS; Teixeira AL; Keefe RS; Rocha FL; Salgado JV
    Braz J Psychiatry; 2016; 38(3):216-21. PubMed ID: 27304257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia.
    Smith MJ; Horan WP; Karpouzian TM; Abram SV; Cobia DJ; Csernansky JG
    Schizophr Res; 2012 May; 137(1-3):196-202. PubMed ID: 22321668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.
    Bowie CR; Reichenberg A; Patterson TL; Heaton RK; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):418-25. PubMed ID: 16513862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia.
    Morra LF; Strauss GP
    Schizophr Res; 2016 Oct; 176(2-3):527-528. PubMed ID: 27397721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
    Milev P; Ho BC; Arndt S; Andreasen NC
    Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.
    Bowie CR; Leung WW; Reichenberg A; McClure MM; Patterson TL; Heaton RK; Harvey PD
    Biol Psychiatry; 2008 Mar; 63(5):505-11. PubMed ID: 17662256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life and cognitive dysfunction in people with schizophrenia.
    Ueoka Y; Tomotake M; Tanaka T; Kaneda Y; Taniguchi K; Nakataki M; Numata S; Tayoshi S; Yamauchi K; Sumitani S; Ohmori T; Ueno S; Ohmori T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):53-9. PubMed ID: 20804809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.